AdvanSix Reports Q3 Loss as Sales Rise but Adjusted EBITDA Declines

AdvanSix reported third-quarter 2026 results on November 4 for the quarter ended September 30. Sales reached $430,807 thousand, up 15% from the prior year, while diluted EPS was ($0.28), adjusted diluted EPS was ($0.24), and adjusted EBITDA was $14,643 thousand. Cash flow from operations rose to $47,962 thousand, and Project CENTURY was selected for a $47 million FIELDS grant.

The release shows weaker adjusted profitability and stronger operating cash generation in the quarter. Investors also face an unresolved difference in the reported 2026 capital-expenditure outlook across the materials.

  • 1Third-quarter sales were $430,807 thousand, up 15% versus the prior year.
  • 2Diluted EPS was ($0.28), while adjusted diluted EPS was ($0.24).
  • 3Adjusted EBITDA was $14,643 thousand, compared with $24,734 thousand in the prior-year quarter.
  • 4Cash flow from operations was $47,962 thousand versus $26,588 thousand in the prior year.
  • 5Project CENTURY was selected for a $47 million FIELDS grant supporting an ammonia platform investment.
  • The 2026 capital-expenditure outlook is inconsistent across the materials, with one report giving approximately $116M and the SEC release giving approximately $90 million.

Sources